TrialThe New England journal of medicine2021
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma.
Thomas Powles et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
673 papers cite itlatest 60 shown
this paperpooled ittrialcites it